Autor(es): Bugalho, M.J.M. ; Wohllk, N. ; Hoff, A.O. ; Cabanillas, M.E.
Data: 2011
Origem: Repositório Institucional da UNL
Assunto(s): iodine 131; protein Ret; protein tyrosine kinase inhibitor; vandetanib; advanced cancer; cancer resistance; chromosomal localization; differentiated thyroid cancer; editorial; epigenetics; fine needle aspiration biopsy; gene expression profiling; gene mutation; genetic screening; genotype phenotype correlation; histopathology; human; incidental finding; lymph node metastasis; medical literature; metastasis; molecularly targeted therapy; oncogene ret; priority journal; risk assessment; risk reduction; thyroid adenoma; thyroid cancer; thyroid follicular carcinoma; thyroid medullary carcinoma; thyroid papillary carcinoma; thyroidectomy; tumor differentiation; tumor microenvironment; tumor volume; unspecified side effect; SDG 3 - Good Health and Well-being
